{"id":58686,"date":"2024-02-28T05:23:06","date_gmt":"2024-02-28T05:23:06","guid":{"rendered":"https:\/\/medsname.com\/lurakem\/"},"modified":"2026-04-30T10:24:10","modified_gmt":"2026-04-30T10:24:10","slug":"lurakem","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/lurakem\/","title":{"rendered":"Lurakem"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fff8d6;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f<\/h3>\n<p style=\"margin-bottom:0;\">Lurakem (Lurasidon 40\/80 mg) je atypick\u00e9 antipsychotikum pro l\u00e9\u010dbu schizofrenie a bipol\u00e1rn\u00ed deprese. <strong>Mus\u00ed se u\u017e\u00edvat s j\u00eddlem (\u2265 350 kcal)<\/strong> \u2014 nala\u010dno se absorpce sni\u017euje na polovinu a vede k ne\u00fasp\u011bchu l\u00e9\u010dby. Metabolicky pat\u0159\u00ed mezi nej\u010dist\u0161\u00ed atypick\u00e1 antipsychotika.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Lurakem na MedsBase je dod\u00e1v\u00e1n p\u0159\u00edmo od v\u00fdrobce certifikovan\u00e9ho WHO-GMP v jednoduch\u00e9m, diskr\u00e9tn\u00edm balen\u00ed. Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00edm <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> \u2014 20pracovn\u00edchdenn\u00ed lh\u016fta pro doru\u010den\u00ed, nebo v\u00e1m z\u00e1silku zdarma p\u0159epo\u0161leme \u2014 a oprav\u0148uje v\u00e1s k \u00fa\u010dasti v na\u0161em <a href=\"https:\/\/medsbase.com\/cs\/loyalty-points\/\">v\u011brnostn\u00edm programu<\/a>. Dod\u00e1v\u00e1me do v\u011bt\u0161iny zem\u00ed po cel\u00e9m sv\u011bt\u011b.<\/p>\n<h2>Co je Lurakem a jak funguje<\/h2>\n<p>Lurakem je tableta lurasidonu dod\u00e1van\u00e1 spole\u010dnost\u00ed Alkem. Dostupn\u00e9 s\u00edly: <strong>40 \/ 80 mg<\/strong>. Lurasidon je antagonista D2\/5-HT2A s dodate\u010dnou antagonizac\u00ed 5-HT7 (komponenta 5-HT7 je z\u00e1kladem pro indikaci u bipol\u00e1rn\u00ed deprese). Pat\u0159\u00ed mezi metabolicky nej\u010dist\u0161\u00ed atypick\u00e1 antipsychotika \u2014 minim\u00e1ln\u00ed p\u0159\u00edr\u016fstek hmotnosti, minim\u00e1ln\u00ed vliv na lipidy, minim\u00e1ln\u00ed vliv na gluk\u00f3zu.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>KL\u00cd\u010cOV\u00c9 \u2014 mus\u00ed se u\u017e\u00edvat s j\u00eddlem (\u2265 350 kcal)<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Biologick\u00e1 dostupnost lurasidonu nala\u010dno je p\u0159ibli\u017en\u011b <strong>polovi\u010dn\u00ed<\/strong> oproti stavu po j\u00eddle. Pacienti, kte\u0159\u00ed vynechaj\u00ed j\u00eddlo nebo u\u017eij\u00ed d\u00e1vku s malou sva\u010dinou, dos\u00e1hnou nedostate\u010dn\u00e9 plazmatick\u00e9 hladiny a \u010dasto se zd\u00e1, \u017ee l\u00e9\u010dba \u201cselh\u00e1v\u00e1\u201d. <strong>U\u017e\u00edvejte s nejv\u011bt\u0161\u00edm j\u00eddlem dne, ka\u017ed\u00fd den ve stejnou dobu.<\/strong> Sklenice ml\u00e9ka nebo mal\u00e1 su\u0161enka nesta\u010d\u00ed \u2014 c\u00edlem je alespo\u0148 350 kcal potravy se sm\u00ed\u0161en\u00fdmi makro\u017eivinami.<\/p>\n<\/div>\n<h2>Indikace a d\u00e1vkov\u00e1n\u00ed<\/h2>\n<table>\n<thead>\n<tr>\n<th>Indikace<\/th>\n<th>Po\u010d\u00e1te\u010dn\u00ed d\u00e1vka<\/th>\n<th>C\u00edlov\u00e1 d\u00e1vka<\/th>\n<th>Maxim\u00e1ln\u00ed d\u00e1vka<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Schizofrenie (dosp\u011bl\u00ed)<\/td>\n<td>40 mg 1\u00d7 denn\u011b s j\u00eddlem<\/td>\n<td>40\u201380 mg 1\u00d7 denn\u011b<\/td>\n<td>160 mg<\/td>\n<\/tr>\n<tr>\n<td>Schizofrenie (dosp\u00edvaj\u00edc\u00ed \u2265 13 let)<\/td>\n<td>40 mg 1\u00d7 denn\u011b s j\u00eddlem<\/td>\n<td>40\u201380 mg 1\u00d7 denn\u011b<\/td>\n<td>80 mg<\/td>\n<\/tr>\n<tr>\n<td>Bipol\u00e1rn\u00ed deprese (dosp\u011bl\u00ed, monoterapie nebo adjuvantn\u00ed l\u00e9\u010dba)<\/td>\n<td>20 mg 1\u00d7 denn\u011b s j\u00eddlem<\/td>\n<td>20\u201360 mg 1\u00d7 denn\u011b<\/td>\n<td>120 mg<\/td>\n<\/tr>\n<tr>\n<td>Bipol\u00e1rn\u00ed deprese (d\u011bti \u2265 10 let)<\/td>\n<td>20 mg 1\u00d7 denn\u011b s j\u00eddlem<\/td>\n<td>20\u201380 mg 1\u00d7 denn\u011b<\/td>\n<td>80 mg<\/td>\n<\/tr>\n<tr>\n<td>Porucha funkce ledvin (CrCl &lt; 50)<\/td>\n<td>20 mg 1\u00d7 denn\u011b s j\u00eddlem<\/td>\n<td>a\u017e 80 mg<\/td>\n<td>80 mg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>D\u016fle\u017eit\u00e9 bezpe\u010dnostn\u00ed aspekty<\/h2>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>FDA black-box \u2014 psych\u00f3za spojen\u00e1 s demenc\u00ed<\/strong><\/p>\n<p style=\"margin-bottom:0;\">V\u0161echna atypick\u00e1 antipsychotika nesou varov\u00e1n\u00ed FDA black-box pro zv\u00fd\u0161enou mortalitu (p\u0159edev\u0161\u00edm kardiovaskul\u00e1rn\u00ed a infek\u010dn\u00ed) p\u0159i pou\u017eit\u00ed k l\u00e9\u010db\u011b behavior\u00e1ln\u00edch poruch u star\u0161\u00edch dosp\u011bl\u00fdch s demenc\u00ed. <strong>Atypick\u00e1 antipsychotika nejsou schv\u00e1lena pro psych\u00f3zu nebo agitovanost spojenou s demenc\u00ed<\/strong>. Pou\u017eit\u00ed u t\u00e9to populace je off-label, posledn\u00ed mo\u017enost\u00ed, \u010dasov\u011b omezen\u00e9 a vy\u017eaduje explicitn\u00ed rozhovor o rizic\u00edch a p\u0159\u00ednosech.<\/p>\n<\/div>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Akathisie a EPS<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Akathisie je \u010dast\u011bj\u0161\u00ed p\u0159i vy\u0161\u0161\u00edch d\u00e1vk\u00e1ch. EPS (rigidita, tremor, dystonie) jsou m\u00e9n\u011b \u010dast\u00e9 ne\u017e u antipsychotik prvn\u00ed generace, ale mohou se vyskytnout. \u0158e\u0161\u00ed se sn\u00ed\u017een\u00edm d\u00e1vky nebo pod\u00e1n\u00edm anticholinergik.<\/p>\n<\/div>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Siln\u00fd substr\u00e1t CYP3A4<\/strong><\/p>\n<p style=\"margin-bottom:0;\">Vyvarujte se sou\u010dasn\u00e9ho pod\u00e1v\u00e1n\u00ed siln\u00fdch inhibitor\u016f CYP3A4 (azoly, klarithromycin, ritonavir, grapefruitov\u00fd d\u017eus) \u2013 mohou n\u011bkolikan\u00e1sobn\u011b zv\u00fd\u0161it hladinu lurasidonu. Vyhn\u011bte se siln\u00fdm induktor\u016fm (rifampicin, karbamazepin, fenytoin, t\u0159ezalka te\u010dkovan\u00e1) \u2013 sni\u017euj\u00ed hladinu na ne\u00fa\u010dinnou \u00farove\u0148.<\/p>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<strong>Sebevra\u017eedn\u00e9 tendence (u osob do 25 let s bipol\u00e1rn\u00ed depres\u00ed)<\/strong><\/p>\n<p style=\"margin-bottom:0;\">V\u0161echny indikace ze skupiny antidepresiv nesou varov\u00e1n\u00ed o riziku sebevra\u017eedn\u00fdch tendenc\u00ed u osob mlad\u0161\u00edch 25 let.<\/p>\n<\/div>\n<h2>\u010cast\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky<\/h2>\n<ul>\n<li><strong>Ospalost a sedace<\/strong> \u2013 \u010dast\u00e9; obvykle ustupuj\u00ed.<\/li>\n<li><strong>Akatizie<\/strong> \u2014 z\u00e1visl\u00e9 na d\u00e1vce.<\/li>\n<li><strong>Nevolnost<\/strong> \u2013 prvn\u00ed 1\u20132 t\u00fddny; zm\u00edrn\u011bno j\u00eddlem (kter\u00e9 je v ka\u017ed\u00e9m p\u0159\u00edpad\u011b povinn\u00e9).<\/li>\n<li><strong>EPS<\/strong> \u2014 m\u00e9n\u011b \u010dast\u00e9, ale mo\u017en\u00e9.<\/li>\n<li><strong>P\u0159ib\u00fdv\u00e1n\u00ed na v\u00e1ze<\/strong> \u2014 m\u00edrn\u00e9, obecn\u011b ni\u017e\u0161\u00ed ne\u017e u olanzapinu\/kvetiapinu.<\/li>\n<li><strong>Prolaktin<\/strong> \u2014 m\u00edrn\u00fd d\u00e1vkov\u011b z\u00e1visl\u00fd vzestup.<\/li>\n<li><strong>V\u00fdznamn\u00e9 absence:<\/strong> minim\u00e1ln\u00ed vliv na lipidy, gluk\u00f3zu, QT interval.<\/li>\n<\/ul>\n<h2>Interakce l\u00e9k\u016f<\/h2>\n<ul>\n<li><strong>Siln\u00e9 inhibitory CYP3A4<\/strong> \u2014 kontraindikov\u00e1no.<\/li>\n<li><strong>Siln\u00e9 induktory CYP3A4<\/strong> \u2014 kontraindikov\u00e1no.<\/li>\n<li><strong>M\u00edrn\u00e9 inhibitory CYP3A4<\/strong> (diltiazem, verapamil, flukonazol, erytromycin) \u2014 sn\u00ed\u017eit d\u00e1vku lurasidonu na polovinu; max. 40 mg.<\/li>\n<li><strong>Jin\u00e1 CNS depresiva<\/strong> \u2014 aditivn\u00ed sedace.<\/li>\n<li><strong>Jin\u00e1 antipsychotika<\/strong> \u2014 aditivn\u00ed riziko EPS, prolaktinu a NMS.<\/li>\n<\/ul>\n<h2>T\u011bhotenstv\u00ed, kojen\u00ed, pediatrie<\/h2>\n<p>T\u011bhotenstv\u00ed: omezen\u00e1 data; zva\u017ete proti nel\u00e9\u010den\u00e9mu onemocn\u011bn\u00ed. Kojen\u00ed: nedostate\u010dn\u00e1 data; obecn\u011b se nedoporu\u010duje. D\u011bti: schv\u00e1leno od 13 let (schizofrenie), 10 let (bipol\u00e1rn\u00ed deprese).<\/p>\n<h2>Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte p\u0159i 15\u201330 \u00b0C v p\u016fvodn\u00edm obalu.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>Pro\u010d je t\u0159eba u\u017e\u00edvat Lurakem s j\u00eddlem?<\/h3>\n<p>Absorpce nala\u010dno je p\u0159ibli\u017en\u011b polovi\u010dn\u00ed oproti absorpci po j\u00eddle. Po\u017eadavek na j\u00eddlo nen\u00ed voliteln\u00fd \u2014 pacienti, kte\u0159\u00ed u\u017e\u00edvaj\u00ed Lurakem nala\u010dno, \u010dasto vypadaj\u00ed, \u017ee terapie selh\u00e1v\u00e1, kdy\u017e ve skute\u010dnosti jsou prost\u011b nedostate\u010dn\u011b d\u00e1vkov\u00e1ni. Minim\u00e1ln\u00ed pr\u00e1h pro dostate\u010dnou absorpci je p\u0159ibli\u017en\u011b 350 kcal sm\u00ed\u0161en\u00e9ho j\u00eddla (norm\u00e1ln\u00ed j\u00eddlo, ne sva\u010dina).<\/p>\n<h3>Pro\u010d je Lurakem preferov\u00e1n pro bipol\u00e1rn\u00ed depresi?<\/h3>\n<p>Lurasidon m\u00e1 schv\u00e1len\u00ed FDA pro l\u00e9\u010dbu bipol\u00e1rn\u00ed deprese jako monoterapie nebo adjuvantn\u00ed l\u00e9\u010dba (studie PREVAIL-2) \u2014 je jedn\u00edm ze t\u0159\u00ed atypick\u00fdch antipsychotik s touto indikac\u00ed (dal\u0161\u00ed jsou kvetiapin a olanzapin-fluoxetin). P\u0159edpokl\u00e1d\u00e1 se, \u017ee antagonismus 5-HT7 stoj\u00ed za antidepresivn\u00edm \u00fa\u010dinkem. Lurasidon je metabolicky \u0161etrn\u011bj\u0161\u00ed volbou ne\u017e kvetiapin nebo olanzapin u bipol\u00e1rn\u00ed deprese.<\/p>\n<h3>Zp\u016fsob\u00ed Lurakem p\u0159ib\u00edr\u00e1n\u00ed na v\u00e1ze?<\/h3>\n<p>M\u00e9n\u011b ne\u017e olanzapin, klozapin, kvetiapin nebo risperidon \u2014 typicky 1\u20132 kg za 6 m\u011bs\u00edc\u016f p\u0159i monoterapii. Jeden z lep\u0161\u00edch metabolick\u00fdch profil\u016f mezi atypick\u00fdmi antipsychotiky.<\/p>\n<h3>Za jak dlouho Lurakem za\u010dne p\u016fsobit?<\/h3>\n<p>Schizofrenie: pozitivn\u00ed p\u0159\u00edznaky se typicky zlep\u0161uj\u00ed b\u011bhem 2\u20134 t\u00fddn\u016f; pln\u00fd \u00fa\u010dinek nast\u00e1v\u00e1 za 4\u20136 t\u00fddn\u016f. Bipol\u00e1rn\u00ed deprese: pln\u00fd \u00fa\u010dinek za 2\u20136 t\u00fddn\u016f. D\u016fle\u017eit\u00e9 je dodr\u017eov\u00e1n\u00ed po\u017eadavku na j\u00eddlo \u2014 pokud je odpov\u011b\u010f nedostate\u010dn\u00e1, ov\u011b\u0159te, zda jsou d\u00e1vky u\u017e\u00edv\u00e1ny s dostate\u010dn\u00fdm j\u00eddlem.<\/p>\n<h3>M\u016f\u017ee b\u00fdt Lurakem kombinov\u00e1n s mood stabiliz\u00e1tory?<\/h3>\n<p>Ano \u2014 lurasidon je schv\u00e1len FDA jako adjuvantn\u00ed l\u00e9\u010dba k lithiu nebo valpro\u00e1tu u bipol\u00e1rn\u00ed deprese. Kombinace je b\u011b\u017en\u00e1 a dob\u0159e tolerovan\u00e1.<\/p>\n<h3>A co \u0159\u00edzen\u00ed pod vlivem Lurakem?<\/h3>\n<p>Sedace je z\u00e1visl\u00e1 na d\u00e1vce. V\u011bt\u0161ina pacient\u016f na stabiln\u00ed d\u00e1vce \u0159\u00edd\u00ed norm\u00e1ln\u011b; prvn\u00ed 1\u20132 t\u00fddny titrace mohou ovlivnit reak\u010dn\u00ed \u010das.<\/p>\n<h3>Jak se Lurakem li\u0161\u00ed od olanzapinu?<\/h3>\n<p>Lurasidon m\u00e1 v\u00fdrazn\u011b lep\u0161\u00ed metabolick\u00fd profil (men\u0161\u00ed p\u0159\u00edr\u016fstek hmotnosti, men\u0161\u00ed gluk\u00f3zov\u00e9 a lipidov\u00e9 poruchy), ale m\u00edrn\u011b vy\u0161\u0161\u00ed v\u00fdskyt akatizie a somnolence. Olanzapin je v\u00edce sedativn\u00ed a m\u00e1 siln\u011bj\u0161\u00ed akutn\u00ed antipsychotick\u00fd \u00fa\u010dinek; lurasidon je preferov\u00e1n pro dlouhodobou metabolickou bezpe\u010dnost.<\/p>\n<h3>M\u016f\u017ee b\u00fdt Lurakem n\u00e1hle vysazen?<\/h3>\n<p>Obecn\u011b se doporu\u010duje vysazov\u00e1n\u00ed postupn\u011b b\u011bhem 1\u20132 t\u00fddn\u016f, a\u010dkoliv abstinen\u010dn\u00ed p\u0159\u00edznaky jsou m\u00edrn\u00e9. Hlavn\u00edm d\u016fvodem opatrnosti je riziko relapsu u schizofrenie a bipol\u00e1rn\u00ed poruchy \u2014 nikdy nevysazujte bez souhlasu p\u0159edepisuj\u00edc\u00edho l\u00e9ka\u0159e.<\/p>\n<h3>Pro\u010d je grapefruitov\u00fd probl\u00e9m?<\/h3>\n<p>Grapefruitov\u00e1 \u0161\u0165\u00e1va je siln\u00fd inhibitor CYP3A4. Lurasidon je substr\u00e1t CYP3A4; grapefruit zvy\u0161uje hladiny n\u011bkolikan\u00e1sobn\u011b, co\u017e zvy\u0161uje riziko sedace, akathisie a EPS. B\u011bhem terapie Lurakem se vyhn\u011bte grapefruitu a grapefruitov\u00e9 \u0161\u0165\u00e1v\u011b.<\/p>\n<h3>Prodlou\u017e\u00ed Lurakem QT interval?<\/h3>\n<p>M\u00e9n\u011b ne\u017e ziprasidon, m\u00e9n\u011b ne\u017e thioridazin. Lurasidon m\u00e1 mal\u00fd vliv na QT interval, ale obecn\u011b je pova\u017eov\u00e1n za jeden z nej\u010dist\u0161\u00edch atypick\u00fdch antipsychotik z hlediska QT. P\u0159ed l\u00e9\u010dbou nen\u00ed rutinn\u011b vy\u017eadov\u00e1no EKG, ale je rozumn\u00e9 u pacient\u016f s kardiovaskul\u00e1rn\u00edmi rizikov\u00fdmi faktory.<\/p>\n<h2>Dal\u0161\u00ed l\u00e9ky na du\u0161evn\u00ed zdrav\u00ed<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/aripicon\/\">Aripicon (Aripiprazol \u2014 parci\u00e1ln\u00ed agonista D2)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/olanzap\/\">Olanzap (Olanzapin \u2014 \u00fa\u010dinn\u00e9 antipsychotikum)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/risdone\/\">Risdone (Risperidon)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/seroquit\/\">Seroquit (Quetiapin \u2014 bipol\u00e1rn\u00ed deprese)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/atlura\/\">Atlura (Lurasidon \u2014 metabolicky neutr\u00e1ln\u00ed)<\/a><\/li>\n<\/ul>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;font-size:0.9em;\">\n<strong>Zdravotn\u00ed prohl\u00e1\u0161en\u00ed.<\/strong> Tato str\u00e1nka m\u00e1 vzd\u011bl\u00e1vac\u00ed charakter a nenahrazuje individu\u00e1ln\u00ed l\u00e9ka\u0159skou radu. Farmakoterapie du\u0161evn\u00edho zdrav\u00ed by m\u011bla b\u00fdt zah\u00e1jena, monitorov\u00e1na a upravov\u00e1na pod dohledem kvalifikovan\u00e9ho l\u00e9ka\u0159e. Pokud vy nebo n\u011bkdo, koho zn\u00e1te, pro\u017e\u00edv\u00e1 sebevra\u017eednou krizi, okam\u017eit\u011b kontaktujte m\u00edstn\u00ed z\u00e1chrann\u00e9 slu\u017eby nebo volejte linku prevence sebevra\u017ed ve va\u0161\u00ed zemi (USA\/Kanada: 988; UK: Samaritans 116 123; mezin\u00e1rodn\u00ed seznam: <a href=\"https:\/\/findahelpline.com\/\" rel=\"nofollow noopener\" target=\"_blank\">findahelpline.com<\/a>).\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Lurakem (Lurasidon 40\/80 mg) \u2014 atypick\u00e9 antipsychotikum s aktivitou na 5-HT7 receptoru pro l\u00e9\u010dbu schizofrenie a bipol\u00e1rn\u00ed deprese. Mus\u00ed se u\u017e\u00edvat s nejv\u011bt\u0161\u00edm j\u00eddlem dne.<\/p>","protected":false},"featured_media":58687,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3342,3906],"product_tag":[4542,4454],"class_list":{"0":"post-58686","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-general-health","8":"product_cat-mental-health-and-psychiatric-medications","9":"product_tag-lurakem","10":"product_tag-lurasidone","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/58686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=58686"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/58687"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=58686"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=58686"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=58686"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=58686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}